Skip to content
Search

Latest Stories

Tim Wentforth named as Boots parent WBA’s new CEO

Walgreens Boots Alliance, Boots UK’s parent company, has appointed Tim Wentforth as its new CEO, effective on 23 October.

He joined WBA at a pivotal time when the company plans to downsize the business while driving execution and creating greater value for employees, patients, customers and shareholders.


Wentforth replaced Rosalind Brewer, who stepped down on 1 September, after two years at the helm.

He joined from Evernorth, Cigna’s health services organisation based in Connecticut, where he served as its founding CEO.

Prior to Cigna, he also held top roles in companies including specialty pharmacy company Accredo and pharmacy benefit manager Express Scripts.

“He is an accomplished and respected leader with profound expertise in the payer and pharmacy space as well as supply chain, IT and Human Resources,” said Stefano Pessina, Executive Chairman, WBA.

“We are confident he is the right person to lead WBA’s next phase of growth into a customer-centric healthcare company.”

WBA shelved its plan to sell Boots in June 2022, citing difficulties for potential buyers in raising necessary funds due to financial market instability.

At present, there is widespread speculation about WBA's second attempt to divest its UK assets as part of its ongoing efforts to tight-size the company.

WBA’s goal is to be the independent partner of choice, not just in pharmacy but also in healthcare services where it can improve healthcare, lower costs, and help patients, the statement added.

In July, Boots announced that it is moving forward with its plan to close 300 stores in the UK, despite significant sales growth in the quarterly results.

The company achieved robust quarterly results, with retail sales climbing by 13.4 percent and a ninth consecutive quarter of market share growth.

“WBA has a differentiated model with the power to build on the company’s pharmacy strength and trusted brand to evolve healthcare delivery,” Wentforth said.

“I believe in WBA’s vision to be the leading partner in reimagining local healthcare and wellbeing for all.”

“I’ve spent my career working to improve the health of the patients we’ve served,” he added.

"I believe WBA is well positioned to deliver more personalised, coordinated care and achieve better outcomes at a lower cost.”

“I fully recognise the challenges that health plans, healthcare providers, pharmacies and retailers are confronting today and am confident that WBA and its customer and patient-focused teams can seize the opportunities of a dynamic marketplace and be the partner of choice,” he further said.

More For You

 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less